Literature DB >> 30852179

Treatment plan consistency with guidelines for older adults with cancer.

Amy R MacKenzie1, Andrea M Barsevick2, Ronald Myers2, Sarah E Hegarty3, Scott W Keith3, Sheel Patel4, Evan Lapinsky5, Joshua Schoppe6, Ulysses Williams7, Andrew E Chapman8.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30852179      PMCID： PMC9305656          DOI： 10.1016/j.jgo.2019.01.022

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN： 1879-4068            Impact factor:   3.929


× No keyword cloud information.
  9 in total

1.  Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.

Authors:  Hui Zhao; Ning Zhang; Vivian Ho; Minming Ding; Weiguo He; Jiangong Niu; Ming Yang; Xianglin L Du; Daria Zorzi; Mariana Chavez-MacGregor; Sharon H Giordano
Journal:  Cancer       Date:  2017-11-15       Impact factor: 6.860

2.  Hematology-Oncology Fellows' Training in Geriatrics and Geriatric Oncology: Findings From an American Society of Clinical Oncology-Sponsored National Survey.

Authors:  Ronald J Maggiore; William Dale; Arti Hurria; Heidi D Klepin; Andrew Chapman; Efrat Dotan; Supriya G Mohile; Arash Naeim; Ajeet Gajra; Mary K Buss
Journal:  J Oncol Pract       Date:  2017-08-24       Impact factor: 3.840

3.  Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer.

Authors:  David D Yang; Brandon A Mahal; Vinayak Muralidhar; Ninjin Boldbaatar; Shelby A Labe; Michelle D Nezolosky; Marie E Vastola; Clair J Beard; Neil E Martin; Kent W Mouw; Peter F Orio; Martin T King; Paul L Nguyen
Journal:  Cancer       Date:  2017-08-22       Impact factor: 6.860

4.  Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies.

Authors:  Thomas E Stinchcombe; Ying Zhang; Everett E Vokes; Joan H Schiller; Jeffrey D Bradley; Karen Kelly; Walter J Curran; Steven E Schild; Benjamin Movsas; Gerald Clamon; Ramaswamy Govindan; George R Blumenschein; Mark A Socinski; Neal E Ready; Wallace L Akerley; Harvey J Cohen; Herbert H Pang; Xiaofei Wang
Journal:  J Clin Oncol       Date:  2017-05-11       Impact factor: 44.544

5.  Effects of guideline adherence in primary breast cancer--a 5-year multi-center cohort study of 3976 patients.

Authors:  Achim Wöckel; Christian Kurzeder; Verena Geyer; Igor Novasphenny; Regine Wolters; Manfred Wischnewsky; Rolf Kreienberg; Dominic Varga
Journal:  Breast       Date:  2010-02-01       Impact factor: 4.380

6.  Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.

Authors:  Supriya G Mohile; William Dale; Mark R Somerfield; Mara A Schonberg; Cynthia M Boyd; Peggy S Burhenn; Beverly Canin; Harvey Jay Cohen; Holly M Holmes; Judith O Hopkins; Michelle C Janelsins; Alok A Khorana; Heidi D Klepin; Stuart M Lichtman; Karen M Mustian; William P Tew; Arti Hurria
Journal:  J Clin Oncol       Date:  2018-05-21       Impact factor: 44.544

7.  A randomized phase II trial of geriatric assessment and management for older cancer patients.

Authors:  Martine T E Puts; Schroder Sattar; Michael Kulik; Mary Ellen MacDonald; Kara McWatters; Katherine Lee; Sarah Brennenstuhl; Raymond Jang; Eitan Amir; Monika K Krzyzanowska; Anthony M Joshua; Johanne Monette; Doreen Wan-Chow-Wah; Shabbir M H Alibhai
Journal:  Support Care Cancer       Date:  2017-07-25       Impact factor: 3.603

8.  Anticipating the "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States.

Authors:  Shirley M Bluethmann; Angela B Mariotto; Julia H Rowland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-07       Impact factor: 4.254

9.  The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people.

Authors:  T Kalsi; G Babic-Illman; P J Ross; N R Maisey; S Hughes; P Fields; F C Martin; Y Wang; D Harari
Journal:  Br J Cancer       Date:  2015-04-14       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.